Cancer epigenetics enters the mainstream. Genetics and genomics must share an ever-widening spotlight

Scientist

Volumn 19, Issue 12, 2005, Pages 18-19

  Greener, Mark ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

EID: 22344441745     PISSN: 08903670     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (10)

1. A.P. Feinberg, B. Vogelstein, "Hypomethylation distinguishes genes of some human cancers from their normal counterparts," Nature, 301:89-92, 1983.
2. A.P. Feinberg, B. Tycko, "The history of cancer epigenetics," Nat Rev Cancer, 4:143-53, 2004.
3. A.P. Feinberg, "Cancer epigenetics takes center stage," Proc Natl Acad Sci, 98:392-4, 2001.
4. L. Di Croce et al., "Methyltransferase recruitment and DNA hypermethylation of target promoters by an oncogenic transcription factor," Science, 295:1079-82, 2002.
5. T. Sakatani et al., "Loss of imprinting of Igf2 alters intestinal maturation and tumorigenesis in mice," Science, 307:1976-8, March 25, 2005.
6. M.F. Fraga et al., "Loss of acetylation at Lys16 and trimethylation at Lys20 of histone H4 is a common hallmark of human cancer," Nat Genet, 37:391-400, April 2005.
7. M.D. Anyway et al., "Epigenetic transgenerational actions of endocrine disruptors and male fertility," Science, 308:1466-9, June 3, 2005.
8. R.A. Waterland, R.L. Jirtle, "Transposable elements: Targets for early nutritional effects on epigenetic gene regulation," Mol Cell Biol, 23:5293-300, 2003.
9. J.P. Issa et al., "Azacitidine," Nat Rev Drug Discov, 4:275-6, April 4, 2005.
10. J.S. Nam et al., "5-aza-2′-deoxycytidine restores the E-cadherin system in E-cadherin-silenced cancer cells and reduces cancer metastasis," Clin Exp Metastasis, 21:49-56, 2004.